14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today AGRX ranks #17803 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$0.34 (-5.03%)

Volume: 1M

Closed: Jan 19, 2022

Hollow Logo Score: -5.865

Agile Therapeutics Stock Forecast

$0.34 (-5.03%)

Volume: 1M

Closed: Jan 19, 2022

Score Hollow Logo -5.865

Agile Therapeutics Company Profile

101 Poor Farm Road

Princeton NJ 08540



Agile Therapeutics


Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE